Wedmont Private Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Wedmont Private Capital's ALNY Position: Q2 2026 in Review
Wedmont Private Capital increased its Alnylam Pharmaceuticals (ALNY) stake by 16% in Q2 2026, buying an estimated $57.6K and bringing the position to 1,413 shares worth $422K. The position accounts for 0.01% of the portfolio, ranked #613.
Wedmont Private Capital first reported a position in ALNY in Q4 2022 and has held it in 10 quarters since. The position peaked at $565K in Q2 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.
- Wedmont Private Capital held 1,413 shares of Alnylam Pharmaceuticals worth $422K as of Q2 2026.
- Wedmont Private Capital bought 191 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $57.6K.
- Alnylam Pharmaceuticals made up 0.01% of Wedmont Private Capital's portfolio in Q2 2026, its #613 holding.
- Wedmont Private Capital first reported a position in Alnylam Pharmaceuticals in Q4 2022 and has held it in 10 quarters since.
- Wedmont Private Capital's Alnylam Pharmaceuticals position peaked at $565K in Q2 2025.
- 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.
Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.